253 related articles for article (PubMed ID: 17917419)
1. [Homocysteine metabolism].
Hashimoto T; Shinohara Y; Hasegawa H
Yakugaku Zasshi; 2007 Oct; 127(10):1579-92. PubMed ID: 17917419
[TBL] [Abstract][Full Text] [Related]
2. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M;
Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016
[TBL] [Abstract][Full Text] [Related]
3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
4. The methionine-homocysteine cycle and its effects on cognitive diseases.
Miller AL
Altern Med Rev; 2003 Feb; 8(1):7-19. PubMed ID: 12611557
[TBL] [Abstract][Full Text] [Related]
5. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
Alemán G; Tovar AR; Torres N
Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine and risk of cardiovascular disease.
Andreotti F; Burzotta F; Manzoli A; Robinson K
J Thromb Thrombolysis; 2000 Jan; 9(1):13-21. PubMed ID: 10590184
[TBL] [Abstract][Full Text] [Related]
7. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.
Dudman NP; Wilcken DE; Wang J; Lynch JF; Macey D; Lundberg P
Arterioscler Thromb; 1993 Sep; 13(9):1253-60. PubMed ID: 8364009
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
9. [Homocysteine and cardiovascular risk].
Auer J; Berent R; Weber T; Lassnig E; Eber B
Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
[TBL] [Abstract][Full Text] [Related]
10. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
Wuillemin WA; Solenthaler M
Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
12. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
13. Methods for measuring sulfur amino acid metabolism.
Hoffer LJ
Curr Opin Clin Nutr Metab Care; 2002 Sep; 5(5):511-7. PubMed ID: 12172474
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins.
Haynes WG
Cardiovasc Drugs Ther; 2002 Sep; 16(5):391-9. PubMed ID: 12652108
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and cardiovascular disease: interactions between nutrition, genetics and lifestyle.
Brosnan JT
Can J Appl Physiol; 2004 Dec; 29(6):773-80. PubMed ID: 15630149
[TBL] [Abstract][Full Text] [Related]
16. [Determination and utilisation of the plasmatic concentration of homocysteine in clinical practice].
Llevadot J; Blanco Vaca F; González Sastre F
Med Clin (Barc); 2005 Apr; 124(14):544-53. PubMed ID: 15847753
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism of genes encoding homocysteine metabolism-related enzymes and risk for cardiovascular disease.
Malinowska A; Chmurzynska A
Nutr Res; 2009 Oct; 29(10):685-95. PubMed ID: 19917447
[TBL] [Abstract][Full Text] [Related]
18. Betaine-homocysteine
Partearroyo T; Murillo-Cuesta S; Vallecillo N; Bermúdez-Muñoz JM; Rodríguez-de la Rosa L; Mandruzzato G; Celaya AM; Zeisel SH; Pajares MA; Varela-Moreiras G; Varela-Nieto I
FASEB J; 2019 May; 33(5):5942-5956. PubMed ID: 30753104
[TBL] [Abstract][Full Text] [Related]
19. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
Kang SS; Rosenson RS
Cardiovasc Drugs Ther; 2018 Apr; 32(2):233-240. PubMed ID: 29679304
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemia.
Córdoba-Porras A; Sánchez-Quesada JL; González-Sastre F; Ordóñez-Llanos J; Blanco-Vaca F
J Mol Med (Berl); 1996 Dec; 74(12):771-6. PubMed ID: 8974018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
